Crispin R. Dass
Crispin R Dass serves as a Lecturer and Cancer Laboratory Head at Victoria University, Melbourne, Australia. He received his Ph.D. degree, majoring in biotechnology, from Charles Sturt University, Australia in 1999. His most significant postdoctoral training was at the Sydney arm of Johnson & Johnson Research, where he looked at the effect of deoxyribozymes on various tumour cells in vitro and in vivo. Most recently, he has been involved in establishing orthotopic models for various tumours such as prostate cancer, breast cancer, osteosarcoma, chondrosarcoma, and liposarcoma in mice and using these to test the efficacy of potential biologically active agents such as PEDF. His laboratory focuses on elucidation of the various signaling molecules that are up- or downregulated as a result of treatment of human tumour cells with PEDF in biological assays for apoptosis, cell cycling, adhesion, invasion, and colony formation. He is on the editorial boards of three journals in the area of oncology. His research interests are drug discovery, development, and delivery for better cancer treatment outcomes.
Biography Updated on 12 December 2011